What to Know About GLP-1 Medications and Weight Management Programs
Learn how Eden connects patients to licensed providers to explore GLP-1 medications as part of medical weight management programs.
Explore insights into your first week using semaglutide, including dosing, potential side effects, and ways to support a positive treatment experience.
Before beginning semaglutide, a licensed healthcare provider will assess your medical history and may recommend lab testing to help determine whether the medication is appropriate for your needs. Semaglutide is typically administered as a subcutaneous injection, which may start with a low dose and gradually increase under clinical supervision.
Steps to prepare:
Licensed healthcare providers you may connect to via the Eden platform may offer clinical guidance, education, and tools such as injection aids to support your treatment experience.
{{primary-cta}}
Individual responses to semaglutide may vary. During the first week, some individuals may notice changes in appetite or digestion as their body adjusts. Below is a general overview of what some people report during the first week of use under the guidance of a licensed healthcare provider.
Some individuals may experience digestive or energy-related symptoms as their body adjusts to semaglutide. These effects have been observed in clinical trials of FDA-approved GLP-1 receptor agonists and often improve with time and proper support.
Commonly reported symptoms may include:
These reactions are generally mild to moderate and may decrease with continued use. However, everyone’s response is different.
Supportive strategies may include:
If symptoms persist or worsen, consult a licensed healthcare provider promptly. Ongoing care and symptom monitoring are available through licensed providers you may connect to via the Eden platform.
During your first week using semaglutide, certain dietary choices may help support comfort and overall well-being. While this medication may influence appetite, nutrition still plays a key role in maintaining energy levels and easing digestive symptoms.
Consider eating more of the following nutrient-dense options:
Try to limit:
Eating smaller, more frequent meals may help reduce stomach discomfort and promote steadier energy levels. These adjustments may be particularly helpful when your body is adapting to semaglutide.
A licensed healthcare provider can help you personalize a nutrition plan based on your medical history and individual health goals.
Light physical activity may help support digestion, energy levels, and overall well-being during the first week of semaglutide treatment. As your body adjusts, gentle movement may also ease common symptoms such as fatigue or mild bloating.
Activities to consider:
As your comfort level increases, you may work toward the general physical activity guidelines recommended by the CDC:
Be sure to listen to your body and adjust your routine gradually. A licensed healthcare provider can help determine what type and level of activity is appropriate for your current health status.
Tracking your experience with semaglutide may help you stay informed and engaged during treatment. While responses to this medication can vary from person to person, observing changes in key areas may support meaningful conversations with your licensed healthcare provider.
You may consider monitoring:
Many people find it helpful to use a journal or tracking app to organize this information. Sharing your notes with a licensed healthcare provider may help guide dosage adjustments, nutrition, and overall care decisions.
Although many individuals tolerate semaglutide well, certain symptoms should be addressed promptly with a licensed healthcare provider. Monitoring for potential side effects is an important part of staying safe while using GLP-1 receptor agonists.
Contact a licensed healthcare provider immediately if you experience:
Licensed healthcare providers on the Eden platform are available to review your symptoms, provide medical guidance, and recommend any next steps based on your individual situation.
The first week of semaglutide treatment marks the beginning of a longer-term approach to metabolic health. While changes may be subtle early on, some individuals report reduced appetite or fewer food-related thoughts during this period. When paired with supportive habits like balanced eating, regular hydration, and light movement, these shifts may contribute to improved well-being over time.
Licensed healthcare providers on the Eden platform may offer personalized care plans designed to guide you safely through each stage of your treatment when eligible. With consistency, support, and monitoring, you may build a strong foundation for long-term lifestyle improvements.
Explore personalized GLP-1 plans with Eden
This article is for educational purposes only and is not intended to diagnose, treat, or substitute for professional medical advice. Always consult a licensed healthcare provider before starting or adjusting any medication or treatment plan. Semaglutide is FDA-approved under the brand names Ozempic® (for type 2 diabetes) and Wegovy® (for chronic weight management in adults with obesity or overweight with related conditions). Use in compounded form or for other health goals should be supervised by a licensed provider and may not be FDA-approved.
Disclaimer: The FDA does not approve compounded medications for safety, quality, or manufacturing. Prescriptions and a medical evaluation are required for certain products. The information provided on this blog is for general informational purposes only. It is not intended as a substitute for professional advice from a qualified healthcare professional and should not be relied upon as personal health advice. The information contained in this blog is not meant to diagnose, treat, cure, or prevent any disease. Readers are advised to consult with a qualified healthcare professional for any medical concerns, including side effects. Use of this blog's information is at your own risk. The blog owner is not responsible for any adverse effects or consequences resulting from the use of any suggestions or information provided in this blog.
Some individuals report losing 2–5 pounds in the first week, which is often attributed to reduced appetite or fluid shifts. Long-term body composition changes typically develop over time and vary based on individual health factors, lifestyle, and provider guidance.
Nausea is among the most commonly reported side effects in the first week of semaglutide use. It may improve with proper hydration, dietary adjustments, and gradual dose increases under the direction of a licensed healthcare provider.
Injectable semaglutide does not require fasting and can be administered with or without food. If you are using an oral formulation, such as Rybelsus®, fasting instructions may apply. Always follow the directions provided by your prescribing provider.
Light physical activity may help support digestion and overall well-being as your body adjusts during the first week. Consider starting with gentle movement, such as walking or stretching, and modify based on your comfort level. Always consult a licensed healthcare provider before beginning or changing any exercise routine during treatment.
Some people notice appetite changes within the first few days, while others may take longer. These effects can vary widely and should be monitored in consultation with your licensed healthcare provider.